Covance bolsters pharmacovigilance services with Sciformix acquisition

By Melissa Fassbender

- Last updated on GMT

(Image: Getty/marchmeena29)
(Image: Getty/marchmeena29)
Covance has acquired Sciformix in a deal that augments the CRO’s pharmacovigilance capabilities for post-approval safety solutions and expands its global footprint.

Covance, LabCorp’s contract research organization (CRO) business, has acquired Sciformix Corporation, a scientific process outsourcing company focused on pharmacovigilance and regulatory solutions.

“Sciformix enhances Covance’s offering, particularly in post-approval pharmacovigilance. Its capabilities are complementary with Covance’s existing Drug and Device Safety Solutions and Adjudication as well as Covance Market Access (CMA),”​ Sue Maynard, vice president, corporate communications, LabCorp, told Outsourcing-Pharma.com.

Sciformix provides post-marketing safety and risk management, clinical development support services, regulatory affairs and operations, technology services, and real-world evidence (RWE) solutions.

Maynard said: “The need for post-approval solutions is driven by many factors including momentum in new product launches, and increasing expectations for safety monitoring during later stages of development and post approval.”

Sciformix – which Maynard said will “largely operate as an independent business unit”​ – has 1,100 employees are based in Asia, further expanding Covance’s global footprint.

Terms of the transaction were not disclosed.

Related news

Show more

Related products

show more

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Products

View more

Webinars